Cyclosporin a treatment increases rat soleus muscle oxidative capacities

Hervé Sanchez, Benoit N'Guessan, Florence Ribera, Renée Ventura-Clapier, Xavier Bigard

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)

Abstract

Previous studies suggested that administration of cyclosporin A (CsA), an immunosuppressive agent, contributes to the increased fatigability of heart transplant recipients. The aim of this study was to investigate whether CsA itself, without vehicle, affects the function of mitochondria maintained in situ, in rats treated with CsA (25mg/kg/day) dissolved in ethanol and olive oil. Treatment with CsA induced a 16% decrease in slow myosin heavy chain (MHC) associated with a 225% increase in fast MHCIIa. The proportion of fibers expressing type IIa MHC increased as a result of CsA treatment. Soleus from the CsA-treated animals showed an increase in both basal (+85%) and maximal (+37%) mitochondrial respiration (P < 0.001), consistent with a 24% increase in citrate synthase activity, whereas the apparent Km for adenosine diphosphate was unchanged. By itself, CsA has no deleterious effects on muscle oxidative capacity but induces alterations in energy metabolism in accordance with the increased proportion of fast-twitch oxidative fibers.

Original languageEnglish
Pages (from-to)324-329
Number of pages6
JournalMuscle and Nerve
Volume28
Issue number3
DOIs
Publication statusPublished - 1 Sep 2003
Externally publishedYes

Keywords

  • Cyclosporin A
  • Mitochondria
  • Muscle fatigue
  • Myosin heavy chain
  • Skeletal muscle
  • Vehicle

Fingerprint

Dive into the research topics of 'Cyclosporin a treatment increases rat soleus muscle oxidative capacities'. Together they form a unique fingerprint.

Cite this